liu.seSearch for publications in DiVA
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Angiotensin II-dependent down-regulation of vascular natriuretic peptide type C receptor gene expression in hypertensive rats
Department of Medicine, Institute of Clinical Endocrinology, Tokyo Women's Medical College, Tokyo, 162, Japan.
Department of Medicine, Institute of Clinical Endocrinology, Tokyo Women's Medical College, Tokyo, 162, Japan.
Department of Medicine, Institute of Clinical Endocrinology, Tokyo Women's Medical College, Tokyo, 162, Japan.
Department of Medicine, Institute of Clinical Endocrinology, Tokyo Women's Medical College, Tokyo, 162, Japan.
Show others and affiliations
1996 (English)In: Endocrinology, ISSN 0013-7227, E-ISSN 1945-7170, Vol. 137, no 3, p. 1102-1107Article in journal (Refereed) Published
Abstract [en]

Biological actions of natriuretic peptide (NP) are determined by the condition of the receptor as well as that of the hormone. Although we previously demonstrated in hypertensive rats the up-regulation of NP-A receptor that mediates various biological actions of NPs, the pathophysiologic significance of NP-C receptor, another subtype thought to be related to clearance of NPs and possibly to biological actions, remains unknown. In the present study, we determined NP-C receptor messenger RNA (mRNA) level in the aortic tissue of stroke-prone spontaneously hypertensive rats (SHR-SP/Izm) and in cultured aortic smooth muscle cells by ribonuclease protection assay. The aortic NP-C receptor mRNA level in SHR-SP/Izm was significantly lower than that in the control WKY/Izm. Oral administration of an angiotensin (Ang) II receptor (AT1) antagonist, TCV-116, but not a calcium channel blocker, manidipine, reversed the down-regulated NP-C receptor mRNA in SHR-SP/Izm to the level in WKY/Izm, whereas the latter was more potent in decreasing the blood pressure. In cultured aortic smooth muscle cells, the NP-C receptor was the predominant subtype. Ang II decreased the NP-C receptor mRNA level in a dose-dependent manner, but this effect was reversed by an AT1 antagonist, CV-11974. Neither the NP-A nor NP-B receptor mRNA level was altered by Ang II. These findings indicate that vascular NP-C receptor is down- regulated via Ang-II-mediated mechanism in SHR-SP/Izm. The phenomenon, together with the up-regulation of the NP-A receptor, may play an important role in counteracting hypertension by enhancing the action of NPs.

Place, publisher, year, edition, pages
Oxford University Press, 1996. Vol. 137, no 3, p. 1102-1107
National Category
Endocrinology and Diabetes
Identifiers
URN: urn:nbn:se:liu:diva-150403DOI: 10.1210/endo.137.3.8603580PubMedID: 8603580Scopus ID: 2-s2.0-9044246056OAI: oai:DiVA.org:liu-150403DiVA, id: diva2:1240659
Available from: 2018-08-22 Created: 2018-08-22 Last updated: 2018-08-30Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full textPubMedScopus

Authority records BETA

Shionoya, Kiseko

Search in DiVA

By author/editor
Shionoya, Kiseko
In the same journal
Endocrinology
Endocrinology and Diabetes

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 6 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf